Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Bomback

Showing results (81-90 of 200) with videos related to

Pageof 20
Sort By:
Advances in Chronic Kidney Disease|November 18, 2019
Lupus Podocytopathy: An OverviewNestor Oliva-Damaso, Juan Payan, Elena Oliva-Damaso, et al.
Journal of Community Medicine & Health Education|July 7, 2017
Evaluation of the Scored Questionnaire to Identify Individuals with Chronic Kidney Disease in a Community-based Screening Program in Rural North CarolinaDonna H Harward, Heejung Bang, Yichun Hu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2026
Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor TherapyAruna K Subramanian, Anuja Java, Samir K Gupta, et al.
Lancet (London, England)|March 29, 2026
Complement biomarkers during iptacopan treatment - Authors' replyDavid Kavanagh, Andrew S Bomback, Marina Vivarelli, et al.
North Carolina Medical Journal|March 5, 2010
The Kidney Education Outreach Program's community-based screenings: participants' demographics and screening resultsDonna H Harward, Andrew S Bomback, Caroline E Jennette, et al.
Glomerular Diseases|April 11, 2025
A Case Report and Literature Review of ANCA-Associated Vasculitis and Lupus Nephritis Overlap: Lessons in ManagementGabriel Dardik, Anna Krieger, Maya K Rao, et al.
Kidney360|April 4, 2022
Late Relapses of Membranous Nephropathy: A Case SeriesYonatan Peleg, Andrew S Bomback, Pietro A Canetta, et al.
Journal of the American Society of Hypertension : JASH|September 22, 2012
Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapyAndrew S Bomback, Yelena Rekhtman, Philip J Klemmer, et al.
Journal of the American Society of Nephrology : JASN|March 4, 2025
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical TrialAndrew S Bomback, Leal C Herlitz, Priyanka Punit Kedia, et al.
The American Journal of Clinical Nutrition|September 11, 2009
Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA)Andrew S Bomback, Ronit Katz, Ka He, et al.
Pageof 20

Showing results (81-90 of 200) with videos related to

Sort By:
Pageof 20
Advances in Chronic Kidney Disease|November 18, 2019
Lupus Podocytopathy: An OverviewNestor Oliva-Damaso, Juan Payan, Elena Oliva-Damaso, et al.
Journal of Community Medicine & Health Education|July 7, 2017
Evaluation of the Scored Questionnaire to Identify Individuals with Chronic Kidney Disease in a Community-based Screening Program in Rural North CarolinaDonna H Harward, Heejung Bang, Yichun Hu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2026
Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor TherapyAruna K Subramanian, Anuja Java, Samir K Gupta, et al.
Lancet (London, England)|March 29, 2026
Complement biomarkers during iptacopan treatment - Authors' replyDavid Kavanagh, Andrew S Bomback, Marina Vivarelli, et al.
North Carolina Medical Journal|March 5, 2010
The Kidney Education Outreach Program's community-based screenings: participants' demographics and screening resultsDonna H Harward, Andrew S Bomback, Caroline E Jennette, et al.
Glomerular Diseases|April 11, 2025
A Case Report and Literature Review of ANCA-Associated Vasculitis and Lupus Nephritis Overlap: Lessons in ManagementGabriel Dardik, Anna Krieger, Maya K Rao, et al.
Kidney360|April 4, 2022
Late Relapses of Membranous Nephropathy: A Case SeriesYonatan Peleg, Andrew S Bomback, Pietro A Canetta, et al.
Journal of the American Society of Hypertension : JASH|September 22, 2012
Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapyAndrew S Bomback, Yelena Rekhtman, Philip J Klemmer, et al.
Journal of the American Society of Nephrology : JASN|March 4, 2025
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical TrialAndrew S Bomback, Leal C Herlitz, Priyanka Punit Kedia, et al.
The American Journal of Clinical Nutrition|September 11, 2009
Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA)Andrew S Bomback, Ronit Katz, Ka He, et al.
Pageof 20